Miles Capital’s Ingevity NGVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-3,427
Closed -$299K 164
2019
Q4
$299K Sell
3,427
-80
-2% -$7K 0.24% 107
2019
Q3
$298K Buy
3,507
+77
+2% +$6.86K 0.25% 109
2019
Q2
$361K Buy
3,430
+21
+0.6% +$2.11K 0.29% 91
2019
Q1
$360K Sell
3,409
-87
-2% -$8.74K 0.31% 83
2018
Q4
$293K Buy
3,496
+128
+4% +$11.6K 0.29% 95
2018
Q3
$343K Sell
3,368
-30
-0.9% -$2.9K 0.28% 100
2018
Q2
$275K Hold
3,398
0.17% 126
2018
Q1
$250K Buy
3,398
+127
+4% +$9.5K 0.14% 160
2017
Q4
$231K Buy
+3,271
New +$236K 0.13% 145

Other funds holding NGVT

Miles Capital's NGVT Position: Q1 2020 in Review

Miles Capital sold out of Ingevity (NGVT) in Q1 2020, closing a stake of 3,427 shares — an estimated $299K sold.

Miles Capital first reported a position in NGVT in Q4 2017 and held it in 9 quarters. The position peaked at $361K in Q2 2019. 272 funds tracked by Wall St. Rank hold NGVT as of Q1 2020.

  • Miles Capital reported no remaining Ingevity position as of Q1 2020 after selling out during the quarter.
  • Miles Capital sold 3,427 Ingevity shares in Q1 2020, an estimated $299K.
  • Miles Capital first reported a position in Ingevity in Q4 2017 and held it in 9 quarters.
  • Miles Capital's Ingevity position peaked at $361K in Q2 2019.
  • 272 funds tracked by Wall St. Rank held Ingevity as of Q1 2020.

Based on Miles Capital's 13F filing for Q1 2020, filed 13 May 2020.